All lobbying filings

TIBER CREEK GROUP

Lobbying for ASTRAZENECA

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $90,000.00 income · posted Apr 18, 2025

Official filing document

Bills named in this filing 1

HR 946
ORPHAN Cures Act

Lobbying activity 1

Medicare/Medicaid

Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Drug Rebate Program (MDRP); Issues related to H.R. 946 - ORPHAN Cures Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.